{"transactions":[{"id":1908441,"issuer":{"id":114006,"kind":"organization","name":"Panacea Acquisition Corp. II","symbol":"PANA"},"owners":[{"id":114007,"kind":"person","name":"EcoR1 Panacea Holdings II, LLC","position":1,"cik":"0001842055","reported_name":"EcoR1 Panacea Holdings II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":2,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":3,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":4,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":5,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":6,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":7,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2023-05-02T17:15:46.000Z","date":"2023-04-28","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":545000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 10, 2023, Panacea Acquisition Corp. II (the \"Company\") announced that it did not consummate an initial business combination by April 9, 2023, the deadline under its Amended and Restated Memorandum and Articles of Association. In connection with the winding up of the Company, the Class A ordinary shares, par value $0.0001 per share, held by the Reporting Persons were surrendered for no consideration on April 28, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 10, 2023, Panacea Acquisition Corp. II (the \"Company\") announced that it did not consummate an initial business combination by April 9, 2023, the deadline under its Amended and Restated Memorandum and Articles of Association. In connection with the winding up of the Company, the Class A ordinary shares, par value $0.0001 per share, held by the Reporting Persons were surrendered for no consideration on April 28, 2023."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reporting owner, EcoR1 Panacea Holdings II, LLC (the \"Sponsor\"), in whose name the securities reported herein were held, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the \"General Partners\"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may have been deemed to be a beneficial owner of the shares held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-026595","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000120919123026595/doc4.xml","form_type":"4"}},{"id":2750513,"issuer":{"id":114006,"kind":"organization","name":"Panacea Acquisition Corp. II","symbol":"PANA"},"owners":[{"id":114007,"kind":"person","name":"EcoR1 Panacea Holdings II, LLC","position":1,"cik":"0001842055","reported_name":"EcoR1 Panacea Holdings II, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":69542,"kind":"person","name":"NODELMAN OLEG","position":2,"cik":"0001454385","reported_name":"NODELMAN OLEG","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Chairman of the Board"}},{"id":109484,"kind":"person","name":"EcoR1 Capital Fund, L.P.","position":3,"cik":"0001567938","reported_name":"EcoR1 Capital Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109485,"kind":"person","name":"EcoR1 Capital Fund Qualified, L.P.","position":4,"cik":"0001598292","reported_name":"EcoR1 Capital Fund Qualified, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109486,"kind":"person","name":"EcoR1 Venture Opportunity Fund, LP","position":5,"cik":"0001778011","reported_name":"EcoR1 Venture Opportunity Fund, LP","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":48279,"kind":"organization","name":"EcoR1 Capital, LLC","position":6,"cik":"0001587114","reported_name":"EcoR1 Capital, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":109487,"kind":"person","name":"Biotech Opportunity GP, LLC","position":7,"cik":"0001816370","reported_name":"Biotech Opportunity GP, LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A ordinary shares","published_at":"2021-04-13T15:10:13.000Z","date":"2021-04-09","kind":"purchase","acquired":true,"shares":545000,"price":10,"value":5450000.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The reporting owner, EcoR1 Panacea Holdings II, LLC (the \"Sponsor\"), in whose name the securities reported herein are held, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the \"General Partners\"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein."}],"balance_after":545000,"source":{"system":"sec-edgar","filing":"0001213900-21-021365","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1816370/000121390021021365/ownership.xml","form_type":"4"}}]}